MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration


SourceLink: Silicon Valley Business Journal

Roche announced today that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. The purchase price is approximately 100 million US dollars ...

... BioImagene is an innovative leader in the field of digital pathology workflow and analysis. Digital pathology is a suite of dynamic, image-based technologies that enable image capture, information management, image analysis and virtual sharing of patients' tissue samples on glass slides...

... BioImagene is headed by Ajit Singh; its chairman is Burrill & Co. founder G. Steven Burrill..

... In 2009, BioImagene Inc. announced a collaboration with the University of Pennsylvania
School of Medicine and Rutgers to develop diagnostics for digital pathology ... BioImagene ... collaborated with researchers and clinicians from Penn and Rutgers University to digitize prostate biopsies, and use telepathology capabilities to collaborate on development and validation of algorithms for diagnostic use...

Read more at:



‘Opportunities multiply as they are seized.’, Sun Tzu

Views: 171

© 2021   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service